ICD code T59.3X2S – Late effect of intentional tear gas exposure

Key takeaways

T59.3X2S is the billable ICD-10-CM code for toxic effect of lacrimogenic gas, intentional self-harm, sequela, valid for FY2025 and FY2026.

The 7th character S marks a sequela visit, so the residual condition is coded first and T59.3X2S is listed second.

The 6th character 2 (intentional self-harm) needs explicit provider documentation and is never inferred from clinical context alone.

Place-of-occurrence codes come from Y92 and activity codes from Y93, and some payers require them on the claim.

Claims management software like Pabau flags incomplete code structures and missing residual condition codes before a claim is submitted.

ICD-10 code T59.3X2S: Definition, billable status, and hierarchy

ICD-10 code T59.3X2S is the specific, billable ICD-10-CM diagnosis code for toxic effect of lacrimogenic gas, intentional self-harm, sequela. It applies at a follow-up visit for a lasting effect of a past, intentional exposure to tear gas or a similar agent. The CMS ICD-10-CM annual release lists it as valid for both FY2025 and FY2026.

The code sits in Chapter 19 of ICD-10-CM. Knowing each parent level helps when a payer LCD policy, crosswalk tool, or audit query cites a category rather than the full code.

• Chapter 19 (S00-T88): Injury, poisoning, and certain other consequences of external causes
• Block T51-T65: Toxic effects of substances chiefly nonmedicinal as to source
• Category T59: Toxic effect of other gases, fumes, and vapors (siblings include T59.0 nitrogen oxides, T59.1 sulfur dioxide, and T59.2 formaldehyde)
• Subcategory T59.3: Lacrimogenic gas, covering all tear-producing agents regardless of formulation
• T59.3X2: Intentional self-harm, not billable without a 7th character
• T59.3X2S: Sequela, the billable endpoint

Code breakdown: What each character of T59.3X2S means

Each character in T59.3X2S carries a specific coding instruction. Misread one position and you get an invalid code or, worse, the wrong intent on the patient’s record.

The placeholder X is not optional. T59.3 has only four characters, so it needs a placeholder in position 5 to push the intent and episode characters into positions 6 and 7. Omitting X produces “T59.32S,” which is an invalid code structure and an automatic payer rejection. Verify against the CDC/NCHS ICD-10-CM web tool whenever a code structure question comes up.

What “sequela” means for T59.3X2S coding

The 7th character S designates a sequela encounter. The active toxic exposure is over, and the patient is now treated for a residual or late effect that persists after healing. Per ICD-10-CM Official Guidelines Section I.B.10, sequela coding takes two codes. The residual condition is sequenced first, and T59.3X2S follows it to record the cause.

A common error is applying S before the acute treatment phase has concluded. If the patient is still being treated for the toxic exposure itself, A or D is correct. Switching to S too early breaks the ICD-10-CM Official Guidelines and misstates the record. Run the same check before you add a psychological sequela, such as situational anxiety, to the claim.

That timing test holds anywhere in the T51-T65 block. T65.4X1S sets the same bar for an accidental carbon disulfide exposure, and its residual condition is sequenced first too. T63.034S covers a taipan venom sequela where the provider could not determine intent, and the residual condition still leads the claim.

T59.3X2S vs. related codes: Choosing the right one

The intent character and episode character together narrow T59.3X2S to a very specific clinical scenario. Confusing either produces a different code entirely, with different legal and billing implications.

Coding as accidental (T59.3X1S) when the record explicitly documents self-harm is a classification error. It understates the clinical picture and may affect mental health follow-up coordination. It can also trigger an audit when the rest of the record tells a different story. When intent is unclear from the documentation, T59.3X4S (undetermined) is the correct choice.

Intent behaves the same way across the other toxic effect subcategories. T52.0X3D carries digit 3 for assault, applied to a petroleum product exposure at a follow-up visit.

What is lacrimogenic gas? Clinical context for coders

Lacrimogenic gas is any chemical agent that causes tearing, burning, and temporary visual impairment upon mucous membrane contact. The ICD-10-CM category T59.3 groups all such agents together regardless of their specific chemical composition.

Agents coded as lacrimogenic gas include CS gas (2-chlorobenzalmalononitrile), CN gas (chloroacetophenone), oleoresin capsicum (OC) spray, and combination aerosols with several irritants. The ICD-10-CM tabular does not list chemical names, so this grouping comes from toxicology literature rather than from the code set itself.

Late effects (sequelae) that may persist after acute exposure and justify the S episode include:

• Chronic conjunctivitis or keratoconjunctivitis
• Reactive airways dysfunction syndrome (RADS) or persistent cough
• Contact dermatitis or chemical sensitization of exposed skin
• Psychological sequelae arising from the self-harm context, coded separately (for example, anxiety or adjustment disorder codes from the F40-F48 range)

Documentation should identify the agent by name where possible. “Tear gas exposure” is acceptable if the specific formulation is not documented. The provider must still note that the agent was lacrimogenic, which supports T59.3 over a more general toxic gas category.

Required external cause coding with T59.3X2S

T59.3X2S already encodes intent in its 6th character, where 2 means intentional self-harm. So it is not paired with a separate X71-X83 intent code, the way a T-code without built-in intent might be. ICD-10-CM Official Guidelines do recommend place-of-occurrence (Y92) and activity (Y93) codes, and some payers enforce them as a hard requirement.

Sequence the codes this way for a T59.3X2S sequela visit:

1. Residual condition code: The late-effect condition treated today, sequenced first. Examples are J68.3 for reactive airway disease, H10.409 for chronic conjunctivitis, or an F-code for a psychological sequela.
2. T59.3X2S: The sequela code that records the toxic exposure behind the residual condition, sequenced second
3. Place-of-occurrence code (Y92): If documented and required by payer policy
4. Activity code (Y93): If documented and required by payer policy

Payer policies on external cause codes vary, so no single code is universally required. Review each payer’s LCD and billing guidelines before you confirm the sequence. Practices that submit through a clearinghouse such as Claim.MD can check code combinations before the payer ever sees them.

Documentation requirements to support T59.3X2S

Four elements must appear in the clinical record to justify T59.3X2S on a claim. Missing any one shifts the code to a less specific or incorrect alternative.

1. Identification of lacrimogenic gas as the toxic agent. The note must name the agent or describe it in terms that unambiguously map to T59.3 (tear gas, CS gas, pepper spray, or similar). “Chemical exposure” without further specificity does not support T59.3 over a more general code.
2. Explicit documentation that the intent was self-harm. This cannot be inferred from clinical context. The provider must state the patient intentionally self-administered or self-exposed to the agent. A note that merely records “patient presented after chemical exposure” without specifying self-harm intent defaults to accidental (T59.3X1S).
3. Confirmation this is a sequela encounter. The record must show that the acute toxic episode has concluded and the patient is being seen today for a residual condition. A phrase such as “late effect of prior tear gas exposure” anchors the S episode character. So do “residual reactive airway disease following prior chemical exposure” and “ongoing conjunctivitis from past tear gas exposure.”
4. Documentation of the specific residual condition being treated. A sequela code without an identified late-effect condition is clinically incomplete and payer-non-compliant. The residual condition must be named, diagnosed, and linked back to the original toxic exposure in the record.

Sequela follow-ups can run for months, so capture all four elements in the note at every visit. A clean claim depends on documentation that maps directly to these ICD-10-CM requirements. The flow below turns the checks into a coding decision, then shows the order the codes go on the claim.

Common claim denial reasons for T59.3X2S

T59.3X2S claims get denied for a short list of predictable reasons. Each one traces back to a documentation or coding error you can catch before submission.

Appealing a denial for any of the first three triggers means sending the relevant section of the clinical note with a cover letter. The letter explains why the specific code is supported. For intent-character mismatches, quote the exact language from the provider’s note. For a missing residual condition code, send a corrected claim that lists that code first.

The guide to CARC denial codes maps each payer code to the trigger behind it. Running these checks before submission surfaces the errors before remittance, not after it.

How claims management software catches T59.3X2S sequela errors

Without a pre-submission check, each sequela claim depends on a coder spotting every error by hand. That means the right 7th character, a residual condition code, and the correct order, every time.

Practice management software like Pabau runs those checks for you. Pabau gives practices claims software built for coders that validates ICD-10-CM code pairs before submission. It flags a sequela code sent without its residual condition, then routes clean claims through the Claim.MD clearinghouse.

Your billing team spends less time on resubmissions and appeals. Payment for sequela follow-ups arrives on the first pass more often, and the patient’s record stays accurate.

Reduce diagnostic code claim denials before they happen

Pabau’s claims management tools validate ICD-10-CM code pairs, flag missing residual condition codes, and route clean claims through Claim.MD before they reach the payer. Book a demo to see how it works for your practice.

Book a demo

Conclusion

Treat T59.3X2S as the second line on the claim, not the first. The residual condition explains why the patient is here today, and the sequela code explains where it came from.

The riskiest character is the 6th. Code self-harm only when the provider has written it down, and fall back to T59.3X4S when the record is silent. A wrong intent misstates the patient’s history, which is harder to correct than a denied claim.

The safest setup makes these checks part of submission, so no coder has to remember them. Book a demo to see how Pabau flags sequela sequencing errors before a T59.3X2S claim leaves your practice.

Continue your research

Need a framework for clean ICD-10-CM claim submission? Clean claim submission outlines the documentation and code-pair standards that prevent rejections at clearinghouse level.

Want to understand how denial codes map to specific claim errors? Denial management in healthcare covers CARC code interpretation and systematic appeal workflows.

Looking for the broader revenue cycle context for diagnostic coding? Revenue cycle management explains how ICD-10-CM codes feed into payment posting and remittance reconciliation.

Frequently asked questions